Key result
A same-day discharge protocol for left atrial appendage occlusion was employed during the COVID-19 pandemic to improve resource utilization and reduce in-hospital virus transmission risk.
Why the study?
A same-day discharge protocol for Watchman LAAO was employed during the COVID-19 pandemic to improve resource utilization, relieve hospital occupation, and reduce in-hospital virus transmission risk.
Does a same-day discharge protocol improve safety, efficacy, and cost-effectiveness in patients with nonvalvular atrial fibrillation undergoing left atrial appendage occlusion?
Does a same-day discharge protocol improve safety, efficacy, and cost-effectiveness in patients with nonvalvular atrial fibrillation undergoing left atrial appendage occlusion?
A same-day discharge protocol for left atrial appendage occlusion was implemented during the COVID-19 pandemic to optimize resource utilization.
May support same-day LAAO discharge feasibility amid resource strain; leaves open safety, efficacy, and cost-effectiveness in nonvalvular AF.
Percutaneous left atrial appendage occlusion (LAAO) with the Watchman device is FDA approved for stroke prevention in patients with nonvalvular atrial fibrillation who have an appropriate indication. During the COVID-19 pandemic, a same-day discharge protocol (SDDP) was employed to improve resource utilization, relieve hospital occupation, and reduce the possible risk of in-hospital virus transmission.
No takes yet. Share an insight, caveat, or question.
Dallan et al. (2022) studied Nonvalvular atrial fibrillation. Same-day discharge protocol (SDDP) for left atrial appendage occlusion was evaluated. A same-day discharge protocol for left atrial appendage occlusion was employed during the COVID-19 pandemic to improve resource utilization and reduce in-hospital virus transmission risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: